These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36008668)

  • 1. A Simple 96-Well Plate-Based Method for Development of Candida Biofilms Under Static Conditions.
    Uppuluri P
    Methods Mol Biol; 2022; 2542():225-231. PubMed ID: 36008668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.
    Pierce CG; Uppuluri P; Tummala S; Lopez-Ribot JL
    J Vis Exp; 2010 Oct; (44):. PubMed ID: 21048668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms.
    Nweze EI; Ghannoum A; Chandra J; Ghannoum MA; Mukherjee PK
    J Antimicrob Chemother; 2012 Jan; 67(1):149-53. PubMed ID: 21990050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; Vande Walle K; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2475-9. PubMed ID: 11502517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.
    Martins M; Henriques M; Lopez-Ribot JL; Oliveira R
    Mycoses; 2012 Jan; 55(1):80-5. PubMed ID: 21668524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay.
    Nett JE; Cain MT; Crawford K; Andes DR
    J Clin Microbiol; 2011 Apr; 49(4):1426-33. PubMed ID: 21227984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 384-Well Microtiter Plate Model for Candida Biofilm Formation and Its Application to High-Throughput Screening.
    Ajetunmobi OH; Wall G; Bonifacio BV; Montelongo-Jauregui D; Lopez-Ribot JL
    Methods Mol Biol; 2023; 2658():53-64. PubMed ID: 37024695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms.
    Rukayadi Y; Hwang JK
    Phytother Res; 2013 Jul; 27(7):1061-6. PubMed ID: 22969012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
    Touil HFZ; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance.
    Uppuluri P; Chaturvedi AK; Lopez-Ribot JL
    Mycopathologia; 2009 Sep; 168(3):101-9. PubMed ID: 19370400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antifungal effect of EDTA, a metal chelator agent, on Candida albicans biofilm.
    Casalinuovo IA; Sorge R; Bonelli G; Di Francesco P
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1413-1420. PubMed ID: 28387883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm-forming capacity of blood-borne Candida albicans strains and effects of antifungal agents.
    Turan H; Demirbilek M
    Rev Argent Microbiol; 2018; 50(1):62-69. PubMed ID: 28988900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
    Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
    Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
    Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
    Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin is more active against Candida albicans biofilms with high metabolic activity.
    Marcos-Zambrano LJ; Escribano P; González del Vecchio M; Bouza E; Guinea J
    J Antimicrob Chemother; 2014 Nov; 69(11):2984-7. PubMed ID: 24942468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.